Osimertinib is a prescription medication used to treat non-small cell lung cancer (NSCLC). That has a specific mutation called epidermal growth factor receptor (EGFR) T790M. The recommended dosage for osimertinib is 80 mg once daily, taken orally with or without food.
It’s important to take osimertinib exactly as prescribed by your doctor. Do not change the dose or stop taking the medication without first consulting with your doctor. Osimertinib can cause side effects, such as diarrhea, rash, nausea, and fatigue, and your doctor may need to adjust your dose or provide other treatments to manage these side effects.
It’s also important to tell your doctor about any other medications you are taking, as they may interact with osimertinib and affect its effectiveness or increase the risk of side effects. Your doctor will monitor you regularly during treatment to ensure that the medication is working properly and to detect any potential complications.
NSCLC stands for non-small cell lung cancer, which is a type of lung cancer that accounts for about 80-85% of all lung cancer cases. NSCLC is a malignant tumor that arises from the tissues of the lung, including the bronchi, bronchioles, and alveoli.
There are several subtypes of NSCLC, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. The different subtypes of NSCLC are characterized by different types of cancer cells and different patterns of growth and spread.
The treatment of NSCLC depends on various factors such as the subtype, stage, and location of the cancer, as well as the patient’s overall health and preferences. Treatment options for NSCLC may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Your doctor will work with you to determine the best treatment plan for your individual situation.
Manufacturer: Everest Pharmaceuticals Ltd.